Aug 06, 2024
2:1
For every share held, investors received 2. The price per share adjusted from $8380.00 to $4190.00.
The split itself did not change the total investment value.
Genome & Co. (KRX:314130) operates in the Pharmaceuticals: major industry.
Genome & Co. company overviewGenome & Co.'s most recent stock split was on August 6, 2024. It was a 2-for-1 forward split, so shareholders received 2 shares for every share they held.
Genome & Co. has split its stock once. This history records one forward split, on August 6, 2024.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Genome & Co.'s 2-for-1 split on August 6, 2024, every share became 2 shares.
Genome & Co. has not announced a new split in our records. Its most recent split was on August 6, 2024, 2 years ago. Companies announce splits in advance, and any new KRX:314130 split will appear on this page.
Already premium?